Fig. 3From: Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology studyCardiac function analysis. Changes in cardiac volumes (a) and contractility (b) 3 weeks post PBS, CM, ASC or CM + ASC administration expressed as relative percentage change vs post infusion. ASC adipose-derived stem cell, CM ASC conditioned media, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, MI myocardial infarctionBack to article page